SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Ortin Laboratories - Quaterly Results

13 Feb 2024 Evaluate
The Sales for the quarter ended December 2023 of Rs. 1.37 million declined by -88.27% from Rs. 11.68 millions.The Net Loss for the quarter ended December 2023 is Rs. -27.92 millions as compared to Net Profit of Rs. 4.55 millions of corresponding quarter ended December 2022Operating profit Margin for the quarter ended December 2023 slipped to -26.03% as compared to 6.20% of corresponding quarter ended December 2022


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202312 202212 % Var 202312 202212 % Var 202303 202203 % Var
Sales 1.37 11.68 -88.27 19.74 45.75 -56.85 60.20 82.31 -26.86
Other Income 0.00 0.00 0.00 0.03 0.01 200.00 0.42 1.94 -78.35
PBIDT -26.03 6.20 -519.84 -33.12 5.95 -656.64 5.63 5.74 -1.92
Interest 1.41 0.99 42.42 4.05 2.79 45.16 3.96 8.11 -51.17
PBDT -27.45 5.21 -626.87 -37.18 3.16 -1276.58 1.67 -2.37 -170.46
Depreciation 0.63 0.73 -13.70 1.81 2.18 -16.97 2.50 2.94 -14.97
PBT -28.08 4.48 -726.79 -38.99 0.98 -4078.57 -0.83 -5.31 -84.37
TAX -0.16 -0.07 128.57 -0.02 -0.13 -84.62 -0.17 -1.31 -87.02
Deferred Tax -0.16 -0.13 23.08 -0.02 -0.19 -89.47 -0.17 -1.31 -87.02
PAT -27.92 4.55 -713.63 -38.97 1.11 -3610.81 -0.66 -4.00 -83.50
Equity 81.31 81.31 0.00 81.31 81.31 0.00 81.31 81.31 0.00
PBIDTM(%) -1900.00 53.08 -3679.35 -167.78 13.01 -1390.08 9.35 6.97 34.11

Ortin Global Share Price

15.00 0.61 (4.24%)
21-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1665.25
Dr. Reddys Lab 1220.75
Cipla 1232.90
Zydus Lifesciences 928.85
Lupin 2311.75
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×